Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.
Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, Mattheus M, Woerle HJ, Broedl UC, Johansen OE, Albers GW, Diener HC; EMPA-REG OUTCOME Investigators (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients). Zinman B, et al. Among authors: diener hc. Stroke. 2017 May;48(5):1218-1225. doi: 10.1161/STROKEAHA.116.015756. Epub 2017 Apr 6. Stroke. 2017. PMID: 28386035 Free PMC article. Clinical Trial.
Assessment of functioning and disability after ischemic stroke.
Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener HC; German Stroke Data Bank Collaborators. Weimar C, et al. Among authors: diener hc. Stroke. 2002 Aug;33(8):2053-9. doi: 10.1161/01.str.0000022808.21776.bf. Stroke. 2002. PMID: 12154262
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.
Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A; SPORTIF Executive Steering Committee for the SPORTIF V Investigators. Albers GW, et al. Among authors: diener hc. JAMA. 2005 Feb 9;293(6):690-8. doi: 10.1001/jama.293.6.690. JAMA. 2005. PMID: 15701910 Clinical Trial.
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Schrader J, et al. Among authors: diener hc. Stroke. 2005 Jun;36(6):1218-26. doi: 10.1161/01.STR.0000166048.35740.a9. Epub 2005 May 5. Stroke. 2005. PMID: 15879332 Clinical Trial.
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csányi A, Schneider D, Klingelhöfer J, Brom J, Weidinger G; PROTECT Trial Group. Diener HC, et al. Stroke. 2006 Jan;37(1):139-44. doi: 10.1161/01.STR.0000195182.67656.ee. Epub 2005 Nov 23. Stroke. 2006. PMID: 16306456 Clinical Trial.
How much esprit is in ESPRIT?
Diener HC. Diener HC. Stroke. 2006 Nov;37(11):2856-7. doi: 10.1161/01.STR.0000244754.18106.85. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990576 Review. No abstract available.
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, Ahlberg G; CHANT Trial Investigators. Lyden PD, et al. Among authors: diener hc. Stroke. 2007 Aug;38(8):2262-9. doi: 10.1161/STROKEAHA.106.472746. Epub 2007 Jun 14. Stroke. 2007. PMID: 17569876 Clinical Trial.
1,394 results